Products & Portfolio (2)
3 discontinued products not shown
ADZENYS XR-ODT
amphetamine extended-release
Peak
ORAL · TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE
non-catecholamine sympathomimetic amines with CNS stimulant activity. The mode of therapeutic action in ADHD is not known. Amphetamines are thought to block the reuptake of norepinephrine and dopamine into the presynaptic neuron and increase the release of these monoamines into the extraneuronal space.
Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 yearsolder
2016
0
COTEMPLA XR-ODT
methylphenidate
Peak
ORAL · TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE
(CNS) stimulant. The mode of therapeutic action in ADHD is not known.
Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 to 17 years of age
2017
0
Open Jobs (0)
No open positions listed yet.
Interview Prep Quick Facts
Portfolio: 5 approved products
Top TAs: Psychiatry
H-1B (2023): 1 approval
Portfolio Health
Peak3 (60%)
Post-LOE2 (40%)
5 total products
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub